Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles

The recent success of monoclonal antibody checkpoint inhibitor therapies that enhance the ability of CD8(+) T cells to detect cancer‐related antigenic peptides has refocused the need to fully understand the repertoire of peptides being presented to the immune system. Whilst the peptide ligandome pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pankaj, Boyne, Caitlin, Brown, Sydney, Qureshi, Ayesha, Thorpe, Peter, Synowsky, Silvia A., Shirran, Sally, Powis, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357481/
https://www.ncbi.nlm.nih.gov/pubmed/35318648
http://dx.doi.org/10.1111/imm.13471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357481/
https://www.ncbi.nlm.nih.gov/pubmed/35318648
http://dx.doi.org/10.1111/imm.13471

Ejemplares similares